title: Multiple sclerosis and the blood-central nervous system barrier.
abstract: The central nervous system (CNS) is isolated from the blood system by a physical barrier that contains efflux transporters and catabolic enzymes. This blood-CNS barrier (BCNSB) plays a pivotal role in the pathophysiology of multiple sclerosis (MS). It binds and anchors activated leukocytes to permit their movement across the BCNSB and into the CNS. Once there, these immune cells target particular self-epitopes and initiate a cascade of neuroinflammation, which leads to the breakdown of the BCNSB and the formation of perivascular plaques, one of the hallmarks of MS. Immunomodulatory drugs for MS are either biologics or small molecules, with only the latter having the capacity to cross the BCNSB and thus have a propensity to cause CNS side effects. However, BCNSB penetration is a desirable feature of MS drugs that have molecular targets within the CNS. These are nabiximols and dalfampridine, which target cannabinoid receptors and potassium channels, respectively. Vascular cell adhesion molecule-1, present on endothelial cells of the BCNSB, also serves as a drug discovery target since it interacts with α4-β1-integrin on leucocytes. The MS drug natalizumab, a humanized monoclonal antibody against α4-β1-integrin, blocks this interaction and thus reduces the movement of immune cells into the CNS. This paper further elaborates on the role of the BCNSB in the pathophysiology and pharmacotherapy of MS.
authors: MS Therapeutics Ltd., Beechey House, 87 Church Street, Crowthorne, Berks RG45 7AW, UK.
authors: Alan M
authors: AM
authors: Palmer
references: Nat Rev Neurol. 2010 Mar;6(3):156-66
references: 20157307
references: Nature. 2011 Aug 10;476(7359):214-9
references: 21833088
references: Lancet Neurol. 2012 Feb;11(2):131-9
references: 22226929
references: Curr Allergy Asthma Rep. 2007 Jul;7(4):285-92
references: 17547851
references: Scand J Immunol. 2007 Oct;66(4):374-82
references: 17850581
references: Curr Pharm Des. 2011;17(26):2762-70
references: 21827407
references: Neurobiol Dis. 2010 Jan;37(1):13-25
references: 19664713
references: Neurobiol Dis. 1999 Jun;6(3):149-66
references: 10408805
references: Expert Rev Neurother. 2012 Apr;12(4 Suppl):9-14
references: 22509986
references: Mult Scler. 2012 Nov;18(11):1577-84
references: 22495945
references: Neurol Sci. 2005 May;26 Suppl 1:S1-2
references: 15883678
references: Acta Neurol Belg. 2012 Dec;112(4):327-33
references: 22767049
references: Clin Neuropharmacol. 2010 Mar-Apr;33(2):91-101
references: 20061941
references: Drugs Today (Barc). 2010 Sep;46(9):635-9
references: 20967295
references: Hum Mol Genet. 2006 Sep 15;15(18):2813-24
references: 16905561
references: J Immunol. 2006 May 15;176(10):6225-34
references: 16670333
references: Neurol Sci. 2001 Nov;22 Suppl 2:S98-102
references: 11794488
references: Neurobiol Dis. 2005 Dec;20(3):953-60
references: 16039866
references: Expert Rev Neurother. 2011 May;11(5):627-37
references: 21456949
references: Eur J Pharmacol. 1988 Jan 5;145(1):15-20
references: 2832183
references: J Immunol. 2007 Dec 15;179(12):8470-9
references: 18056394
references: J Immunol. 2005 Jul 15;175(2):1267-75
references: 16002731
references: Blood. 2003 Apr 15;101(8):3249-56
references: 12480716
references: CNS Drugs. 2005;19(11):909-22
references: 16268663
references: J Exp Med. 2007 Oct 1;204(10):2363-72
references: 17846150
references: Curr Opin Investig Drugs. 2010 Nov;11(11):1313-23
references: 21157651
references: Minerva Med. 2008 Apr;99(2):119-40
references: 18431322
references: Ann Neurol. 2005 Dec;58(6):840-6
references: 16283615
references: J Leukoc Biol. 2009 Nov;86(5):1049-63
references: 19696154
references: Psychopharmacology (Berl). 2012 Feb;219(3):859-73
references: 21796370
references: Mult Scler. 2012 Feb;18(2):153-63
references: 21828200
references: Neurology. 1999 Aug 11;53(3):466-72
references: 10449105
references: Nat Med. 2007 Oct;13(10):1173-5
references: 17828272
references: J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):1039-43
references: 20639385
references: Neurology. 1996 Apr;46(4):907-11
references: 8780061
references: Immunol Rev. 2012 Jul;248(1):87-103
references: 22725956
references: Lancet. 2008 Oct 25;372(9648):1502-17
references: 18970977
references: Immunol Rev. 2009 Jul;230(1):75-96
references: 19594630
references: N Engl J Med. 2006 Mar 2;354(9):924-33
references: 16510746
references: Rev Neurosci. 2010;21(1):29-53
references: 20458886
references: Discov Med. 2011 Mar;11(58):187-96
references: 21447278
references: Curr Pharm Des. 2008;14(16):1555-65
references: 18673197
references: Ann Neurol. 2010 Oct;68(4):494-502
references: 20976768
references: Clin Ther. 2012 May;34(5):1056-69
references: 22497693
references: Brain. 2006 Aug;129(Pt 8):1953-71
references: 16632554
references: Acta Neuropathol. 2012 May;123(5):627-38
references: 22327362
references: Lancet Neurol. 2006 Apr;5(4):343-54
references: 16545751
references: Lancet Neurol. 2012 Apr;11(4):349-60
references: 22441196
references: Neurobiol Dis. 2010 Jan;37(1):38-47
references: 19818851
references: Radiology. 2011 Jun;259(3):659-81
references: 21602503
references: Drug Discov Today. 2012 Oct;17(19-20):1068-78
references: 22580061
references: FEBS Lett. 2011 Dec 1;585(23):3770-80
references: 21550344
references: Annu Rev Immunol. 2005;23:683-747
references: 15771584
references: PLoS One. 2011 Jan 13;6(1):e16149
references: 21249154
references: N Engl J Med. 2012 Jan 26;366(4):339-47
references: 22276823
references: Acta Neurol Scand. 2012 Dec;126(6):384-9
references: 22404677
references: J Neurol. 2011 Nov;258(11):1920-8
references: 21647730
references: Neurobiol Dis. 2010 Jan;37(1):3-12
references: 19664711
references: Semin Immunol. 2002 Apr;14(2):73-81
references: 11978079
references: Curr Treat Options Neurol. 2009 May;11(3):193-202
references: 19364454
references: N Engl J Med. 1986 Dec 25;315(26):1638-42
references: 3785335
references: PLoS One. 2010 Sep 01;5(9):
references: 20824132
references: J Neuroimmunol. 2005 Sep;166(1-2):193-6
references: 16005524
references: J Neuroimmunol. 2010 Apr 15;221(1-2):7-14
references: 19931190
references: Immunol Rev. 2009 Jul;230(1):97-113
references: 19594631
references: J Neuroimmunol. 2011 Mar;232(1-2):207-8
references: 21051092
references: Blood. 2003 Jun 15;101(12):4775-82
references: 12595306
references: Expert Rev Neurother. 2012 Sep;12(9):1061-76; quiz 1077
references: 23039386
references: Brain. 2005 Nov;128(Pt 11):2705-12
references: 16230320
references: Lancet Neurol. 2007 Oct;6(10):903-12
references: 17884680
references: FASEB J. 2010 Apr;24(4):1023-34
references: 19940258
references: J Neurol Sci. 2008 Nov 15;274(1-2):23-6
references: 18573502
references: Nature. 1992 Mar 5;356(6364):63-6
references: 1538783
references: Neurology. 2010 Jan 5;74 Suppl 1:S2-8
references: 20038759
references: Mult Scler. 2011 Jun;17(6):647-57
references: 21372117
references: Trends Immunol. 2007 Jan;28(1):12-8
references: 17129764
references: Br J Pharmacol. 2011 Oct;164(4):1079-106
references: 21371012
references: Mult Scler Int. 2011;2011:461304
references: 22096637
references: Brain Res. 1984 Jun 18;304(1):166-9
references: 6744035
references: Ann Neurol. 2011 Dec;70(6):897-912
references: 22190364
references: Cochrane Database Syst Rev. 2011 Oct 05;(10):CD007621
references: 21975773
references: Neurology. 2009 Dec 8;73(23):1996-2002
references: 19996074
references: Nature. 2007 Jul 26;448(7152):474-9
references: 17568699
references: AJNR Am J Neuroradiol. 2006 Feb;27(2):455-61
references: 16484429
references: Ann Pharmacother. 2012 Jul-Aug;46(7-8):1010-5
references: 22764324
references: Curr Opin Neurol. 2012 Aug;25(4):402-9
references: 22691759
references: Adv Exp Med Biol. 2012;724:222-38
references: 22411246
references: Brain. 2008 Mar;131(Pt 3):808-17
references: 18234696
references: Clin Immunol. 2012 Jan;142(1):49-56
references: 21367665
references: Ther Adv Neurol Disord. 2011 Mar;4(2):99-109
references: 21694807
references: Nature. 2009 Nov 5;462(7269):94-8
references: 19829296
references: Mt Sinai J Med. 2011 Mar-Apr;78(2):221-30
references: 21425266
references: CNS Neurol Disord Drug Targets. 2012 Aug;11(5):624-41
references: 22583441
references: Annu Rev Physiol. 1998;60:161-77
references: 9558459